These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19125351)

  • 1. Clinical and molecular features of mitochondrial DNA depletion syndromes.
    Spinazzola A; Invernizzi F; Carrara F; Lamantea E; Donati A; Dirocco M; Giordano I; Meznaric-Petrusa M; Baruffini E; Ferrero I; Zeviani M
    J Inherit Metab Dis; 2009 Apr; 32(2):143-58. PubMed ID: 19125351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.
    El-Hattab AW; Scaglia F
    Neurotherapeutics; 2013 Apr; 10(2):186-98. PubMed ID: 23385875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene.
    Chanprasert S; Wang J; Weng SW; Enns GM; Boué DR; Wong BL; Mendell JR; Perry DA; Sahenk Z; Craigen WJ; Alcala FJ; Pascual JM; Melancon S; Zhang VW; Scaglia F; Wong LJ
    Mol Genet Metab; 2013; 110(1-2):153-61. PubMed ID: 23932787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of the mitochondrial DNA depletion syndrome.
    Dimmock D; Tang LY; Schmitt ES; Wong LJ
    Clin Chem; 2010 Jul; 56(7):1119-27. PubMed ID: 20448188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene.
    Bornstein B; Area E; Flanigan KM; Ganesh J; Jayakar P; Swoboda KJ; Coku J; Naini A; Shanske S; Tanji K; Hirano M; DiMauro S
    Neuromuscul Disord; 2008 Jun; 18(6):453-9. PubMed ID: 18504129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients.
    Navarro-Sastre A; Tort F; Garcia-Villoria J; Pons MR; Nascimento A; Colomer J; Campistol J; Yoldi ME; López-Gallardo E; Montoya J; Unceta M; Martinez MJ; Briones P; Ribes A
    Mol Genet Metab; 2012 Nov; 107(3):409-15. PubMed ID: 22980518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations.
    Collins J; Bove KE; Dimmock D; Morehart P; Wong LJ; Wong B
    Neuromuscul Disord; 2009 Nov; 19(11):784-7. PubMed ID: 19736010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotype and genotype of twelve Chinese children with mitochondrial DNA depletion syndromes].
    Dai LF; Fang F; Liu ZM; Shen DM; Ding CH; Li JW; Ren XT; Wu HS
    Zhonghua Er Ke Za Zhi; 2019 Mar; 57(3):211-216. PubMed ID: 30818899
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical, biochemical, cellular and molecular characterization of mitochondrial DNA depletion syndrome due to novel mutations in the MPV17 gene.
    Uusimaa J; Evans J; Smith C; Butterworth A; Craig K; Ashley N; Liao C; Carver J; Diot A; Macleod L; Hargreaves I; Al-Hussaini A; Faqeih E; Asery A; Al Balwi M; Eyaid W; Al-Sunaid A; Kelly D; van Mourik I; Ball S; Jarvis J; Mulay A; Hadzic N; Samyn M; Baker A; Rahman S; Stewart H; Morris AA; Seller A; Fratter C; Taylor RW; Poulton J
    Eur J Hum Genet; 2014 Feb; 22(2):184-91. PubMed ID: 23714749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes.
    Wang L; Limongelli A; Vila MR; Carrara F; Zeviani M; Eriksson S
    Mol Genet Metab; 2005 Jan; 84(1):75-82. PubMed ID: 15639197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder.
    Randolph LM; Jackson HA; Wang J; Shimada H; Sanchez-Lara PA; Wong DA; Wong LJ; Boles RG
    Mol Genet Metab; 2011 Feb; 102(2):149-52. PubMed ID: 21093335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
    Carrozzo R; Verrigni D; Rasmussen M; de Coo R; Amartino H; Bianchi M; Buhas D; Mesli S; Naess K; Born AP; Woldseth B; Prontera P; Batbayli M; Ravn K; Joensen F; Cordelli DM; Santorelli FM; Tulinius M; Darin N; Duno M; Jouvencel P; Burlina A; Stangoni G; Bertini E; Redonnet-Vernhet I; Wibrand F; Dionisi-Vici C; Uusimaa J; Vieira P; Osorio AN; McFarland R; Taylor RW; Holme E; Ostergaard E
    J Inherit Metab Dis; 2016 Mar; 39(2):243-52. PubMed ID: 26475597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations.
    El-Hattab AW; Li FY; Schmitt E; Zhang S; Craigen WJ; Wong LJ
    Mol Genet Metab; 2010 Mar; 99(3):300-8. PubMed ID: 20074988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene.
    Oskoui M; Davidzon G; Pascual J; Erazo R; Gurgel-Giannetti J; Krishna S; Bonilla E; De Vivo DC; Shanske S; DiMauro S
    Arch Neurol; 2006 Aug; 63(8):1122-6. PubMed ID: 16908738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mutations in TK2 gene associated with mitochondrial DNA depletion.
    Galbiati S; Bordoni A; Papadimitriou D; Toscano A; Rodolico C; Katsarou E; Sciacco M; Garufi A; Prelle A; Aguennouz M'; Bonsignore M; Crimi M; Martinuzzi A; Bresolin N; Papadimitriou A; Comi GP
    Pediatr Neurol; 2006 Mar; 34(3):177-85. PubMed ID: 16504786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene.
    Mancuso M; Filosto M; Bonilla E; Hirano M; Shanske S; Vu TH; DiMauro S
    Arch Neurol; 2003 Jul; 60(7):1007-9. PubMed ID: 12873860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion.
    Lesko N; Naess K; Wibom R; Solaroli N; Nennesmo I; von Döbeln U; Karlsson A; Larsson NG
    Neuromuscul Disord; 2010 Mar; 20(3):198-203. PubMed ID: 20083405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis in 16 patients with mtDNA depletion.
    Carrozzo R; Bornstein B; Lucioli S; Campos Y; de la Pena P; Petit N; Dionisi-Vici C; Vilarinho L; Rizza T; Bertini E; Garesse R; Santorelli FM; Arenas J
    Hum Mutat; 2003 Apr; 21(4):453-4. PubMed ID: 12655576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characteristics of mitochondrial DNA depletion syndrome associated with neonatal cholestasis and liver failure.
    Al-Hussaini A; Faqeih E; El-Hattab AW; Alfadhel M; Asery A; Alsaleem B; Bakhsh E; Ali A; Alasmari A; Lone K; Nahari A; Eyaid W; Al Balwi M; Craig K; Butterworth A; He L; Taylor RW
    J Pediatr; 2014 Mar; 164(3):553-9.e1-2. PubMed ID: 24321534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of mtDNA: syndromes and genes.
    Alberio S; Mineri R; Tiranti V; Zeviani M
    Mitochondrion; 2007; 7(1-2):6-12. PubMed ID: 17280874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.